Bank of America’s Mustang Bio MBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-54
| Closed | -$53 | – | 6411 |
|
|
2025
Q4 | $53 | Buy |
54
+2
| +4% | +$3 | ﹤0.01% | 6947 |
|
|
2025
Q3 | $79 | Buy |
52
+19
| +58% | +$34 | ﹤0.01% | 7905 |
|
|
2025
Q2 | $32 | Buy |
33
+17
| +106% | +$21 | ﹤0.01% | 8178 |
|
|
2025
Q1 | $20 | Buy |
16
+8
| +100% | +$30 | ﹤0.01% | 8138 |
|
|
2024
Q4 | $75 | Buy |
8
+1
| +14% | +$11 | ﹤0.01% | 7798 |
|
|
2024
Q3 | $78 | Buy |
7
+4
| +133% | +$66 | ﹤0.01% | 7760 |
|
|
2024
Q2 | $70 | Hold |
3
| – | – | ﹤0.01% | 7780 |
|
|
2024
Q1 | $151 | Sell |
3
-1
| -25% | -$64 | ﹤0.01% | 7367 |
|
|
2023
Q4 | $285 | Hold |
4
| – | – | ﹤0.01% | 7329 |
|
|
2023
Q3 | $438 | Hold |
4
| – | – | ﹤0.01% | 7329 |
|
|
2023
Q2 | $1.31K | Sell |
4
-2
| -33% | -$502 | ﹤0.01% | 7207 |
|
|
2023
Q1 | $1.75K | Buy |
6
+2
| +50% | +$820 | ﹤0.01% | 7241 |
|
|
2022
Q4 | $1.31K | Hold |
4
| – | – | ﹤0.01% | 7302 |
|
|
2022
Q3 | $1K | Sell |
4
-19
| -83% | -$8.8K | ﹤0.01% | 7677 |
|
|
2022
Q2 | $10K | Hold |
23
| – | – | ﹤0.01% | 7390 |
|
|
2022
Q1 | $17K | Sell |
23
-39
| -63% | -$32K | ﹤0.01% | 7584 |
|
|
2021
Q4 | $77K | Buy |
62
+31
| +100% | +$50.1K | ﹤0.01% | 7005 |
|
|
2021
Q3 | $62K | Buy |
31
+17
| +121% | +$36.5K | ﹤0.01% | 6950 |
|
|
2021
Q2 | $35K | Sell |
14
-37
| -73% | -$90.7K | ﹤0.01% | 6969 |
|
|
2021
Q1 | $126K | Buy |
51
+27
| +113% | +$80.3K | ﹤0.01% | 6292 |
|
|
2020
Q4 | $68K | Buy |
24
+16
| +200% | +$38.2K | ﹤0.01% | 6181 |
|
|
2020
Q3 | $20K | Sell |
8
-6
| -43% | -$14.8K | ﹤0.01% | 6283 |
|
|
2020
Q2 | $32K | Buy |
14
+4
| +40% | +$9.35K | ﹤0.01% | 6139 |
|
|
2020
Q1 | $20K | Sell |
10
-3
| -23% | -$7.69K | ﹤0.01% | 6177 |
|
|
2019
Q4 | $39K | Sell |
13
-6
| -32% | -$13.7K | ﹤0.01% | 6324 |
|
|
2019
Q3 | $48K | Buy |
19
+2
| +12% | +$5.47K | ﹤0.01% | 6333 |
|
|
2019
Q2 | $46K | Buy |
17
+11
| +183% | +$31.4K | ﹤0.01% | 6334 |
|
|
2019
Q1 | $15K | Sell |
6
-8
| -57% | -$22.7K | ﹤0.01% | 6561 |
|
|
2018
Q4 | $31K | Buy |
14
+8
| +133% | +$24.3K | ﹤0.01% | 6371 |
|
|
2018
Q3 | $28K | Buy |
6
+1
| +20% | +$5K | ﹤0.01% | 6400 |
|
|
2018
Q2 | $25K | Hold |
5
| – | – | ﹤0.01% | 6433 |
|
|
2018
Q1 | $45K | Buy |
+5
| New | +$42.6K | ﹤0.01% | 6083 |
|
Other funds holding MBIO
KAS
VFT
VCM
CG
TRCT
Bank of America's MBIO Position: Q1 2026 in Review
Bank of America sold out of Mustang Bio (MBIO) in Q1 2026, closing a stake of 54 shares — an estimated $53 sold.
Bank of America first reported a position in MBIO in Q1 2018 and held it in 32 quarters. The position peaked at $126K in Q1 2021. 22 funds tracked by Wall St. Rank hold MBIO as of Q1 2026.
- Bank of America reported no remaining Mustang Bio position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 54 Mustang Bio shares in Q1 2026, an estimated $53.
- Bank of America first reported a position in Mustang Bio in Q1 2018 and held it in 32 quarters.
- Bank of America's Mustang Bio position peaked at $126K in Q1 2021.
- 22 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.